Key information relating to the preferential rights issue to be carried out by PCI Biotech Holding ASA

Date on which the terms and conditions of the preferential rights issue were
announced:  24 august 2018

Last day including right: 14 September 2018

Ex-date: 17 September 2018

Record Date: 18 September 2018

Date of approval: 14 September 2018

Maximum number of new shares: 12,000,000

Subscription price: 30

Will the rights be listed: yes



This information is published in accordance with the requirements of the
Continuing Obligations.